Clinical Research

Aresus Pharma GmbH

Address
Kastanienallee 46

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
11
research centres
public
1
country
person_search
10
investigators

Specializations

Dermatology and Actinic Keratosis

Aresus Pharma GmbH focuses on actinic keratosis of the scalp and face, with clinical interest centered on treatment of sun-damaged skin lesions in adult patients.

  • Actinic keratosis
  • Scalp and facial skin lesions
  • Keratinocyte-related skin disease

The sponsor’s research activity in this area is directed toward topical management of precancerous dermatologic lesions and outcomes related to lesion clearance.

Topical Therapeutics

The clinical program includes interest in ointment-based treatment for localized skin disease, with emphasis on skin-directed therapy applied to defined treatment areas.

  • Topical dermatologic formulations
  • Skin lesion clearance
  • Localized treatment of epidermal disorders

Research activity reflects a therapeutic focus on non-systemic intervention for visible and accessible dermatologic conditions.

Inflammatory and Precancerous Skin Conditions

The sponsor’s medical interests include conditions associated with chronic UV-induced skin damage and early-stage cutaneous neoplasia, particularly lesions requiring active dermatologic treatment.

  • Precancerous cutaneous lesions
  • Sun-exposed skin pathology
  • Field-directed skin therapy

This area aligns with clinical evaluation of therapies intended for lesion resolution in exposed skin regions.

Skin Oncology Prevention

Aresus Pharma GmbH is involved in clinical research relevant to the prevention of progression from actinic keratosis toward more serious cutaneous malignancy, with attention to early intervention in dermatologic care.

  • Early skin cancer prevention
  • Non-melanoma skin cancer risk reduction
  • Therapy for premalignant skin lesions

The funded research supports therapeutic development in dermatology with a prevention-oriented clinical emphasis.

Sponsored Trials

Trial Name Country Status
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Adaptive Phase 3 Study to Evaluate the Efficacy and Safety of Sinecatechins (Defined Extract of Green Tea Leaves) Ointment in Adult Patients with Actinic Keratosis of the Scalp and the Face.Germany GermanyRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 11 sites collaborated multiple times

This sponsor has worked with 11 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors

Partnered Research Centres

11 centres
location_city
assignment25
Dermatologie Quist
Address
Haifa-Allee 20, 55128 Mainz
Learn morearrow_forward
location_city
assignment3
Gemeinschaftspraxis Weber & Crainic
Address
Böheimstrasse 8, 86153 Augsburg
Learn morearrow_forward
location_city
assignment3
Hautarztpraxis Dr. Wilfried Steinborn
Address
Theresienplatz 8, 94315 Straubing
Learn morearrow_forward
location_city
assignment3
Hautarztzentrum Hamm
Address
Friedrichstraße 20, 59065 Hamm
Learn morearrow_forward
location_city
assignment12
HLPC Haut- und Lasercentrum Potsdam
Address
Kurfürstenstr. 40, 14467 Potsdam
Learn morearrow_forward
location_city
assignment11
Praxis Dr. med. Abdou Zarzour
Address
Große Steinstr. 12, 06108 Halle
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Aresus Pharma GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.